Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide
- PMID: 32237088
- DOI: 10.1002/jbmr.4001
Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide
Comment in
-
Reply to Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide.J Bone Miner Res. 2020 May;35(5):996-997. doi: 10.1002/jbmr.4000. Epub 2020 Apr 16. J Bone Miner Res. 2020. PMID: 32298496 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources

